P22303 |
ACES_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P22303 |
ACES_HUMAN |
Glaucoma [ICD-11: 9C61] |
P22303 |
ACES_HUMAN |
Myasthenia gravis [ICD-11: 8C6Y] |
P22303 |
ACES_HUMAN |
Oesophageal/gastroduodenal disorder [ICD-11: DD90] |
P22303 |
ACES_HUMAN |
Pediculosis [ICD-11: 1G00] |
P22303 |
ACES_HUMAN |
Unspecific substance harmful effect [ICD-11: NE6Z] |
P22303 |
ACES_HUMAN |
Mild neurocognitive disorder [ICD-11: 6D71] |
P22303 |
ACES_HUMAN |
Parasitic worm infestation [ICD-11: 1F90] |
P22303 |
ACES_HUMAN |
Dementia [ICD-11: 6D80-6D8Z] |
P22303 |
ACES_HUMAN |
Pain [ICD-11: MG30-MG3Z] |
P22303 |
ACES_HUMAN |
Parkinsonism [ICD-11: 8A00] |
P22303 |
ACES_HUMAN |
Substance abuse [ICD-11: 6C40] |
P22303 |
ACES_HUMAN |
Lips/oral mucosa miscellaneous disorder [ICD-11: DA02] |
P22303 |
ACES_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P22303 |
ACES_HUMAN |
Urinary system disease [ICD-11: GC2Z] |
P22303 |
ACES_HUMAN |
Neurodegenerative disorder [ICD-11: 8A20-8A23] |
P05067 |
A4_HUMAN |
Diagnostic imaging [ICD-11: N.A.] |
P05067 |
A4_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P05067 |
A4_HUMAN |
Desmoid tumour [ICD-11: 2F7C] |
P05067 |
A4_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P05067 |
A4_HUMAN |
Retinopathy [ICD-11: 9B71] |
P05067 |
A4_HUMAN |
Dystrophic epidermolysis bullosa [ICD-11: EC32] |
P05067 |
A4_HUMAN |
Amyloidosis [ICD-11: 5D00] |
P05067 |
A4_HUMAN |
Macular degeneration [ICD-11: 9B75] |
P05067 |
A4_HUMAN |
Intracranial injury [ICD-11: NA07] |
P05067 |
A4_HUMAN |
Brain cancer [ICD-11: 2A00] |
P05067 |
A4_HUMAN |
Dissociative neurological symptom disorder [ICD-11: 6B60] |
P05067 |
A4_HUMAN |
Mild neurocognitive disorder [ICD-11: 6D71] |